Page last updated: 2024-10-30

lorazepam and Disruptive, Impulse Control, and Conduct Disorders

lorazepam has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 3 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santos-Cubiñá, J1
Torres-Rodríguez, A1
Castaing-Lespier, PA1
Sabaté, N1
Torres-Martin, A1
Carlo, S1
Morgan, PT1
Malison, RT1
Rätz Bravo, AE1
Zimmermann, T1
Haschke, M1

Trials

1 trial available for lorazepam and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Pilot study of lorazepam and tiagabine effects on sleep, motor learning, and impulsivity in cocaine abstinence.
    The American journal of drug and alcohol abuse, 2008, Volume: 34, Issue:6

    Topics: Adult; Cocaine-Related Disorders; Cognition Disorders; Disruptive, Impulse Control, and Conduct Diso

2008

Other Studies

2 other studies available for lorazepam and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report.
    Boletin de la Asociacion Medica de Puerto Rico, 2013, Volume: 105, Issue:3

    Topics: Adult; Antidepressive Agents; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Benzo

2013
[Lamotrigine and the skin].
    Praxis, 2010, Mar-17, Volume: 99, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Depressive Disorder; Diagnosis, Differential; Disruptiv

2010